Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04406662

Routine Evaluation of People Living With Cancer

Routine Evaluation of People Living With Cancer - Body Composition, Physical Function, Systemic Inflammatory Response, Quality of Life and Symptoms

Status
Recruiting
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
University of Edinburgh · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

People with incurable cancer often have complex individual needs, however there are several common themes encountered when considering this group. As cancer progresses there are series of interactions between the tumour and the patient, producing both local and systemic effects. This altered state of illness can have multiple ill effects including weight loss, fatigue, increased symptom burden and reduction in physical function which all contribute to a reduced quality of life. These areas are often studied in isolation, giving an incomplete picture. A detailed, holistic characterisation of this group of people does not exist. A robust characterisation of people with incurable cancer will allow identification and prioritisation of future research and has the potential to inform new therapeutics and provide justification for treatments. This study aims to collect information about symptoms and quality of life, weight loss and body composition, physical activity and the body's immune response to cancer. Participants with incurable cancer will be recruited to the study from oncology and palliative medicine services in the UK. Participants will answer questionnaires about quality of life and symptoms, have bloods taken for inflammatory marker and cytokine analysis and have their body composition measured by a variety of methods.

Conditions

Timeline

Start date
2020-07-15
Primary completion
2029-08-08
Completion
2029-08-08
First posted
2020-05-28
Last updated
2025-07-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04406662. Inclusion in this directory is not an endorsement.